Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

3.51
Delayed Data
As of Jul 22
 0.00 / 0.00%
Today’s Change
3.49
Today|||52-Week Range
46.40
-79.59%
Year-to-Date
Institutional investors purchased a net $820.6 thousand shares of OREX during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 66.51% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Other institutional53.56%
Individual stakeholders32.01%
Mutual fund holders12.95%

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

7/08/2016BVF PARTNERS LP  Bought 7.3 Million shares of Orexigen Therapeutics Inc
7/08/2016THE BAUPOST GROUP LLC  Bought 5.0 Million shares of Orexigen Therapeutics Inc
6/30/2016CREATIVE PLANNING, INC.  Bought 61.7 Thousand shares of Orexigen Therapeutics Inc

Top 10 Owners of Orexigen Therapeutics Inc

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
The Baupost Group LLC18.73%27,268,39011,725,408+4,999,991+22.45%
BlackRock Fund Advisors5.30%7,711,1763,315,806+72,489+0.95%
The Vanguard Group, Inc.5.23%7,613,2913,273,715+1,556,809+25.70%
BVF Partners LP5.05%7,349,7703,160,401+7,349,770--
Fidelity Management & Research Co...4.85%7,055,9023,034,038-356,854-4.81%
Samlyn Capital LLC4.23%6,160,4172,648,97900.00%
Franklin Advisers, Inc.2.81%4,086,9881,757,405-237,512-5.49%
Morgan Stanley Smith Barney LLC (...1.88%2,736,8411,176,842-145,041-5.03%
Credit Suisse Securities (USA) LL...1.79%2,609,9741,122,289+134,729+5.44%
Renaissance Technologies LLC1.64%2,381,1001,023,873+614,900+34.81%

Top 10 Mutual Funds Holding Orexigen Therapeutics Inc

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change